Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Dose-ranging Study of the Safety and Efficacy of Fluticasone Propionate and Salmeterol Xinafoate in Healthy Patients With Abdominal Contour Defects

NCT01712451 is registered in ClinicalTrials.gov with Neothetics, Inc as lead sponsor.

NCT NCT01712451
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01712451 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Dose-ranging Study of the Safety and Efficacy of Fluticasone Propionate and Salmeterol Xinafoate in Healthy Patients With Abdominal Contour Defects
Lead sponsor
Neothetics, Inc
Phase
Phase 2
Overall status
Completed
Start date
August 31, 2011
Completion date
October 31, 2012
Enrollment
200 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

abdominal contour defects